Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 7 (2010), Issue 2 (February)

1. Psychiatric symptoms in caregivers of patients with bipolar disorder: a review.
   J Affect Disord, 121(1): 10-21. [Abstract] [Full-text]
2. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study.
   J Affect Disord, 121(1): 156-60. [Abstract] [Full-text]
3. Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study.
   J Affect Disord, 121(1): 100-5. [Abstract] [Full-text]
4. Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
   J Affect Disord, 121(1): 116-26. [Abstract] [Full-text]
5. In-patient care costs of patients with bipolar I disorder: a comparison between two European centers.
   J Affect Disord, 121(1): 152-5. [Abstract] [Full-text]
6. Severe affective and behavioral dysregulation in youth is associated with increased serum TSH.
   J Affect Disord, 121(1): 184-8. [Abstract] [Full-text]
7. Onset-age of bipolar disorders at six international sites.
   J Affect Disord, 121(1): 143-6. [Abstract] [Full-text]
8. Lifetime co-morbidity with different subtypes of eating disorders in 148 females with bipolar disorders.
   J Affect Disord, 121(1): 147-51. [Abstract] [Full-text]
9. Cyclothymic temperament and major depressive disorder: a study on Italian patients.
   J Affect Disord, 121(3): 199-203. [Abstract] [Full-text]
10. Early stages in the development of bipolar disorder.
    J Affect Disord, 121(1): 127-35. [Abstract] [Full-text]
11. Bipolar disorder as a risk factor for repeat DUI behavior.
    J Affect Disord, 121(3): 253-7. [Abstract] [Full-text]
12. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
    J Affect Disord, 121(1): 106-15. [Abstract] [Full-text]
13. Anterior genu corpus callosum and impulsivity in suicidal patients with bipolar disorder.
    Neurosci Lett, 469(1): 75-80. [Abstract] [Full-text]
14. Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS).
    Psychiatry Res, 175(3): 221-6. [Abstract] [Full-text]
15. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
    Psychiatry Res, 175(1): 63-6. [Abstract] [Full-text]
16. Cholesterol and affective morbidity.
    Psychiatry Res, 175(1): 78-81. [Abstract] [Full-text]
17. Sexually Transmitted Disease (STD) Diagnoses and Mental Health Disparities Among Women Who Have Sex With Women Screened at an Urban Community Health Center, Boston, MA, 2007.
    Sex Transm Dis, 37(1): 5-12. [Abstract] [Full-text]
18. Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study.
    Br J Psychiatry, 196(2): 109-15. [Abstract] [Full-text]
19. Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study.
    Br J Psychiatry, 196(2): 102-8. [Abstract] [Full-text]
20. The Kraepelinian dichotomy - going, going... but still not gone.
    Br J Psychiatry, 196(2): 92-5. [Abstract] [Full-text]
21. Predicting onset of bipolar disorder from subsyndromal symptoms: a signal question?
    Br J Psychiatry, 196(2): 87-8. [Abstract] [Full-text]
22. Mania complicated with delirium following cessation of long-term lithium therapy.
    Gen Hosp Psychiatry, 32(1): 102-104. [Abstract] [Full-text]
23. Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care.
    Aust N Z J Psychiatry, 44(2): 99-108. [Abstract] [Full-text]
24. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.
    Lancet, 375(9712): 385-95. [Abstract] [Full-text]
25. Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism.
    J Affect Disord, 121(1): 68-72. [Abstract] [Full-text]
26. Postsynaptic PDLIM5/Enigma Homolog binds SPAR and causes dendritic spine shrinkage.
    Mol Cell Neurosci, 43(2): 188-200. [Abstract] [Full-text]
27. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S).
    Schizophr Res, 116(2): 243-51. [Abstract] [Full-text]
28. Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication.
    Neuroimage, 49(4): 2966-76. [Abstract] [Full-text]
29. Thalamic volumes in patients with bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
30. Genome-wide association study of recurrent early-onset major depressive disorder.
    Mol Psychiatry. [Abstract] [Full-text]
31. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families.
    Arch Gen Psychiatry, 67(2): 168-77. [Abstract] [Full-text]
32. Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia.
    Arch Gen Psychiatry, 67(2): 155-66. [Abstract] [Full-text]
33. The mood stabilizer lamotrigine produces antidepressant behavioral effects in rats: role of brain-derived neurotrophic factor.
    J Psychopharmacol. [Abstract] [Full-text]
34. Predictors of decertification from involuntary hospitalization for patients with bipolar disorder.
    Psychiatr Serv, 61(2): 200-3. [Abstract] [Full-text]
35. Weekend prescribing practices and subsequent seclusion and restraint in a psychiatric inpatient setting.
    Psychiatr Serv, 61(2): 193-5. [Abstract] [Full-text]
36. One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP-BD.
    Psychiatr Serv, 61(2): 164-72. [Abstract] [Full-text]
37. Positive screens for psychiatric disorders in primary care: a long-term follow-up of patients who were not in treatment.
    Psychiatr Serv, 61(2): 151-9. [Abstract] [Full-text]
38. The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: A study on Bipolar I Italian National sample.
    J Affect Disord. [Abstract] [Full-text]
39. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Int Clin Psychopharmacol, 25(2): 60-7. [Abstract] [Full-text]
40. Vesicular monoamine transporters: Structure-function, pharmacology, and medicinal chemistry.
    Med Res Rev. [Abstract] [Full-text]
41. Association between AKT1 but not AKTIP genetic variants and increased risk for suicidal behavior in bipolar patients.
    Genes Brain Behav. [Abstract] [Full-text]
42. Lord Clive did not suffer a mood disorder.
    Australas Psychiatry, 18(1): 28-31. [Abstract] [Full-text]
43. Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance.
    J Psychopharmacol. [Abstract] [Full-text]
44. The long-term effectiveness of clozapine and lamotrigine in a patient with treatment-resistant rapid-cycling bipolar disorder.
    J Psychopharmacol. [Abstract] [Full-text]
45. Genetic contribution to individual variation in binocular rivalry rate.
    Proc Natl Acad Sci U S A, 107(6): 2664-8. [Abstract] [Full-text]
46. Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder.
    Curr Opin Clin Nutr Metab Care, 13(2): 130-8. [Abstract] [Full-text]
47. A functional MRI study of verbal fluency in adults with bipolar disorder and their unaffected relatives.
    Psychol Med. [Abstract] [Full-text]
48. Biomarkers in psychiatry: drawbacks and potential for misuse.
    Int Arch Med, 3: 1. [Abstract] [Full-text]
49. Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1.
    Bipolar Disord, 12(1): 102-6. [Abstract] [Full-text]
50. N-methyl-D-aspartate receptor expression in parvalbumin-containing inhibitory neurons in the prefrontal cortex in bipolar disorder.
    Bipolar Disord, 12(1): 95-101. [Abstract] [Full-text]
51. Does lithium protect against dementia?
    Bipolar Disord, 12(1): 87-94. [Abstract] [Full-text]
52. High cortisol levels in the offspring of parents with bipolar disorder during two weeks of daily sampling.
    Bipolar Disord, 12(1): 77-86. [Abstract] [Full-text]
53. The relationship between religious involvement and clinical status of patients with bipolar disorder.
    Bipolar Disord, 12(1): 68-76. [Abstract] [Full-text]
54. Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD.
    Bipolar Disord, 12(1): 56-67. [Abstract] [Full-text]
55. Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder.
    Bipolar Disord, 12(1): 45-55. [Abstract] [Full-text]
56. Development and psychometric evaluation of the Bipolar Functional Status Questionnaire (BFSQ).
    Bipolar Disord, 12(1): 32-44. [Abstract] [Full-text]
57. Ten-year diagnostic consistency of bipolar disorder in a first-admission sample.
    Bipolar Disord, 12(1): 21-31. [Abstract] [Full-text]
58. Occupational status and social adjustment six months after hospitalization early in the course of bipolar disorder: a prospective study.
    Bipolar Disord, 12(1): 10-20. [Abstract] [Full-text]
59. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence.
    Bipolar Disord, 12(1): 1-9. [Abstract] [Full-text]
60. A role for white matter abnormalities in the pathophysiology of bipolar disorder.
    Neurosci Biobehav Rev, 34(4): 533-54. [Abstract] [Full-text]
61. Brain lipid concentrations in bipolar disorder.
    J Psychiatr Res, 44(3): 177-82. [Abstract] [Full-text]
62. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment.
    J Psychiatr Res, 44(3): 143-8. [Abstract] [Full-text]
63. Heart rate variability in bipolar mania and schizophrenia.
    J Psychiatr Res, 44(3): 168-76. [Abstract] [Full-text]
64. Anatomy of bipolar disorder and schizophrenia: a meta-analysis.
    Schizophr Res, 117(1): 1-12. [Abstract] [Full-text]
65. DNA damage after intracerebroventricular injection of ouabain in rats.
    Neurosci Lett, 471(1): 6-9. [Abstract] [Full-text]
66. Attributions for hallucinations in bipolar affective disorder.
    Behav Cogn Psychother, 38(2): 221-6. [Abstract] [Full-text]
67. Distinguishing affective depersonalization from anhedonia in major depression and bipolar disorder.
    Compr Psychiatry, 51(2): 187-92. [Abstract] [Full-text]
68. Current alcohol use and risk for hypomania in male students: generally more or more binging?
    Compr Psychiatry, 51(2): 171-6. [Abstract] [Full-text]
69. A comparison of life events in patients with unipolar disorder or bipolar disorder and controls.
    Compr Psychiatry, 51(2): 157-64. [Abstract] [Full-text]
70. Clinical characteristics of depressed outpatients previously overdiagnosed with bipolar disorder.
    Compr Psychiatry, 51(2): 99-105. [Abstract] [Full-text]
71. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
    Mol Psychiatry. [Abstract] [Full-text]
72. Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria.
    J Psychopharmacol. [Abstract] [Full-text]
73. Patterns of psychiatric and physical comorbidities associated with panic disorder in a nationwide population-based study in Taiwan.
    Acta Psychiatr Scand. [Abstract] [Full-text]
74. Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.
    CNS Drugs, 24(3): 245-62. [Abstract] [Full-text]
75. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.
    Neurobiol Dis, 37(3): 596-603. [Abstract] [Full-text]
76. Elevated amygdala activity to sad facial expressions: a state marker of bipolar but not unipolar depression.
    Biol Psychiatry, 67(5): 414-21. [Abstract] [Full-text]
77. Self-discrepancy in students with bipolar disorder II or NOS.
    J Behav Ther Exp Psychiatry, 41(2): 135-9. [Abstract] [Full-text]
78. Two-dimensional genome scan identifies multiple genetic interactions in bipolar affective disorder.
    Biol Psychiatry, 67(5): 478-86. [Abstract] [Full-text]
79. Sleep, illness course, and concurrent symptoms in inter-episode bipolar disorder.
    J Behav Ther Exp Psychiatry, 41(2): 145-9. [Abstract] [Full-text]
80. Workplace productivity, employment issues, and resource utilization in patients with bipolar I disorder.
    J Med Econ, 13(1): 23-32. [Abstract] [Full-text]
81. Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial.
    Biol Psychiatry, 67(5): 432-8. [Abstract] [Full-text]
82. Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder.
    Prostaglandins Leukot Essent Fatty Acids, 82(2): 111-9. [Abstract] [Full-text]
83. Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization.
    Psychiatr Clin North Am, 33(1): 67-82. [Abstract] [Full-text]
84. The role of genetics in the etiology of schizophrenia.
    Psychiatr Clin North Am, 33(1): 35-66. [Abstract] [Full-text]
85. Abnormal left and right amygdala-orbitofrontal cortical functional connectivity to emotional faces: state versus trait vulnerability markers of depression in bipolar disorder.
    Biol Psychiatry, 67(5): 422-31. [Abstract] [Full-text]
86. Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder.
    BMC Med Genet, 11: 14. [Abstract] [Full-text]
87. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders.
    Mol Psychiatry, 15(3): 326-36. [Abstract] [Full-text]
88. Population-based linkage analysis of schizophrenia and bipolar case-control cohorts identifies a potential susceptibility locus on 19q13.
    Mol Psychiatry, 15(3): 319-25. [Abstract] [Full-text]
89. Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study.
    BMC Psychiatry, 10: 9. [Abstract] [Full-text]
90. Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder.
    J Child Adolesc Psychopharmacol, 20(1): 25-32. [Abstract] [Full-text]
91. Neural correlates of response inhibition in pediatric bipolar disorder.
    J Child Adolesc Psychopharmacol, 20(1): 15-24. [Abstract] [Full-text]
92. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
    J Child Adolesc Psychopharmacol, 20(1): 7-14. [Abstract] [Full-text]
93. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.
    Prog Neuropsychopharmacol Biol Psychiatry, 34(2): 308-12. [Abstract] [Full-text]
94. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls.
    Prog Neuropsychopharmacol Biol Psychiatry, 34(2): 313-6. [Abstract] [Full-text]
95. Comorbidity between bipolar disorder and alcohol use disorder: association of dopamine and serotonin gene polymorphisms.
    Psychiatry Res, 176(1): 30-3. [Abstract] [Full-text]
96. Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain.
    J Neural Transm, 117(3): 309-16. [Abstract] [Full-text]
97. What have the genomics ever done for the psychoses?
    Psychol Med, 40(4): 529-40. [Abstract] [Full-text]
98. Family functioning among adolescents with bipolar disorder.
    J Fam Psychol, 24(1): 60-7. [Abstract] [Full-text]
99. Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment.
    Am J Physiol Renal Physiol, 298(3): F601-8. [Abstract] [Full-text]
100. Identification of targeted analyte clusters for studies of schizophrenia.
     Mol Cell Proteomics, 9(3): 510-22. [Abstract] [Full-text]
101. Polymorphism screening of brain-expressed FABP7, 5 and 3 genes and association studies in autism and schizophrenia in Japanese subjects.
     J Hum Genet, 55(2): 127-30. [Abstract] [Full-text]
102. Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder.
     Aust N Z J Psychiatry, 44(3): 220-9. [Abstract] [Full-text]
103. Self-mutilation and suicide attempts: relationships to bipolar disorder, borderline personality disorder, temperament and character.
     Aust N Z J Psychiatry, 44(3): 250-7. [Abstract] [Full-text]
104. Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorder.
     Am J Med Genet B Neuropsychiatr Genet, 153(2): 484-93. [Abstract] [Full-text]
105. Investigation of an epistastic effect between a set of TAAR6 and HSP-70 genes variations and major mood disorders.
     Am J Med Genet B Neuropsychiatr Genet, 153(2): 680-3. [Abstract] [Full-text]
106. Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples.
     Am J Med Genet B Neuropsychiatr Genet, 153(2): 494-502. [Abstract] [Full-text]
107. Support of association between BRD1 and both schizophrenia and bipolar affective disorder.
     Am J Med Genet B Neuropsychiatr Genet, 153(2): 582-91. [Abstract] [Full-text]
108. Sex-specific association of the Reelin gene with bipolar disorder.
     Am J Med Genet B Neuropsychiatr Genet, 153(2): 549-53. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.